The Future Oncology Portfolio: Build, Buy or Be Left Behind?
For this event, we will welcome participants at Reception 92 (Building 92) https://www.google.com/maps?q47.55948,7.609076
The oncology landscape is transforming at an unprecedented rate. Join industry leaders from Pharma, Biotech, and VC as they dive into strategic portfolio evolution, company creation, and investment trends shaping tomorrow's therapies.
Key themes will explore:
-
Building a New Entrant: The BeOne story
-
Investment & Innovation: Outlook and reflections on 15 years of investing in oncology
-
Expert Panel: Strategic approaches to building, scaling, and sustaining competitive oncology franchises
The evening will conclude with a networking apéro bringing together professionals from business development, licensing, R&D, and investment.
Featured Speakers
- Building a new entrant in Oncology – the BeOne story - Giancarlo Benelli, Senior Vice President, Head of Europe at BeOne Medicines
- Outlook and reflections on 15 years of investing in oncology - Thilo Schroeder, Managing Partner at Nextech Invest
Panel Discussion
- Stefanie Granado, Therapeutic Area Head, Oncology International at Novartis International
- Guillaume Cettou, Exeuctive Director Diagnostics, Oncology Translational Medicine at GSK
- Bruno Gomes, Head of Early Development Oncology at Roche
We look forward to welcoming you for an engaging evening of knowledge-sharing and networking.
For this event, we will welcome participants at Roche - Reception 92 (Building 92)
Merken heißt eintragen.
- Ein Tipp, und das Event steht in deinem Kalender.Mit Erinnerung, mit Adresse, mit Anfahrt.
- Folge Roche Reception 92 (Building 92).Der Ort meldet sich, wenn das nächste Event eingetragen ist.